Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-03

Clinical Trial Update: Pregabalin and Alpha-lipoic Acid Combination Versus Each Monotherapy in Patients With Diabetic Peripheral Neuropathy [Phase 4]

View source ↗

Summary

A Phase 4 trial compared the combination of pregabalin and alpha-lipoic acid to each monotherapy in patients with diabetic peripheral neuropathy and has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alpha Lipoic Acid (alpha-lipoic acid)
  • Lyrica (Pregabalin)

Snippet

Sponsor: Yuhan Corporation | Conditions: Diabetic Peripheral Neuropathy | Phase 4 | Status: COMPLETED